CeriBell, Inc. has grown revenue 40% a year over three years and 40% a year over five. Revenue growth, 3-year annual rate: +40% (Medical Devices median +12%). Revenue growth, 5-year rate: +40%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

CBLLCeriBell, Inc.

Healthcare

$23.15+96% 1Y

$23.15

$10.9252 weeks$25.01

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +32% year on year, but operating margin narrowing (−1.5 points).

1 good, 1 to watch, 1 without data

Revenue trend+32% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−1.5 points operating

Trailing-twelve-month operating margin, -68.3% now against -66.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CBLL growing?

CeriBell, Inc. has grown revenue 40% a year over three years and 40% a year over five.

+40%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +40%
Revenue growth, 5-year rate · +40% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›